Patient Characteristics
| . | FAB Type . | Sex . | Age . | PB/BM . | % Blasts . | Response to Therapy . |
|---|---|---|---|---|---|---|
| 1 | ALL (L1) | F | 39 | PB | 58 | * CR |
| 2 | ALL (L1) | F | 19 | BM | 84 | * PR |
| 3 | ALL (L2) | M | 42 | BM | 40 | NR |
| 4 | ALL (L2) | M | 56 | BM | 38 | PR |
| 5 | ALL (L2) | M | 59 | PB | 80 | * CR |
| 6 | ALL (L2) | F | 68 | PB | 31 | * CR |
| 7 | AML (M1) | F | 45 | BM | 47 | * CR |
| 8 | AML (M1) | M | 45 | BM | 59 | * CR |
| 9 | AML (M1) | M | 56 | BM | 76 | * CR |
| 10 | AML (M1) | M | 54 | PB | 91 | * NR |
| 11 | AML (M1) | M | 52 | PB | 78 | * PR |
| 12 | AML (M2) | M | 38 | PB | 70 | NR |
| 13 | AML (M2) | M | 47 | BM | 71 | * CR |
| 14 | AML (M2) | M | 67 | BM | 48 | CR |
| 15 | AML (M2) | M | 75 | BM | 70 | * PR |
| 16 | AML (M2) | M | 58 | PB | 91 | * CR |
| 17 | AML (M2) | F | 21 | PB | 70 | * PR |
| 18 | AML (M3) | F | 41 | BM | 40 | * CR |
| 19 | AML (M3) | M | 69 | PB | 57 | * CR |
| . | FAB Type . | Sex . | Age . | PB/BM . | % Blasts . | Response to Therapy . |
|---|---|---|---|---|---|---|
| 1 | ALL (L1) | F | 39 | PB | 58 | * CR |
| 2 | ALL (L1) | F | 19 | BM | 84 | * PR |
| 3 | ALL (L2) | M | 42 | BM | 40 | NR |
| 4 | ALL (L2) | M | 56 | BM | 38 | PR |
| 5 | ALL (L2) | M | 59 | PB | 80 | * CR |
| 6 | ALL (L2) | F | 68 | PB | 31 | * CR |
| 7 | AML (M1) | F | 45 | BM | 47 | * CR |
| 8 | AML (M1) | M | 45 | BM | 59 | * CR |
| 9 | AML (M1) | M | 56 | BM | 76 | * CR |
| 10 | AML (M1) | M | 54 | PB | 91 | * NR |
| 11 | AML (M1) | M | 52 | PB | 78 | * PR |
| 12 | AML (M2) | M | 38 | PB | 70 | NR |
| 13 | AML (M2) | M | 47 | BM | 71 | * CR |
| 14 | AML (M2) | M | 67 | BM | 48 | CR |
| 15 | AML (M2) | M | 75 | BM | 70 | * PR |
| 16 | AML (M2) | M | 58 | PB | 91 | * CR |
| 17 | AML (M2) | F | 21 | PB | 70 | * PR |
| 18 | AML (M3) | F | 41 | BM | 40 | * CR |
| 19 | AML (M3) | M | 69 | PB | 57 | * CR |
Abbreviations: CR, complete remission; PR, partial remission; NR no response.
First induction.